MoonLake Immunotherapeutics

Historical 13F Holders

Symbol
MLTX
CUSIP
61559X104
All holders as of
Q1 2025
Type
Equity
Class
CLASS A ORD
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q1 153 59.7 M $2.33 B
2024 Q4 130 63.2 M $3.42 B
2024 Q3 119 62.1 M $3.13 B
2024 Q2 129 61.6 M $2.71 B
2024 Q1 140 59.9 M $3.01 B
2023 Q4 156 59.8 M $3.56 B
2023 Q3 136 56.5 M $3.22 B
2023 Q2 87 56.3 M $2.87 B
2023 Q1 44 39.4 M $843 M
2022 Q4 34 37.7 M $396 M
2022 Q3 25 36.9 M $291 M
2022 Q2 24 36.5 M $190 M
2022 Q1 1 654 k $7.26 M